The Kislinger Laboratory is located at the Princess Margaret Cancer Research Tower of the Princess Margaret Cancer Centre, the largest oncology treatment and research facility in Canada. The major goal of our lab is to apply proteomics technologies to cancer and cardiovascular research. Our research interests include technology development, using the latest generation of mass spectrometry instrumentation, basic cell biology and translational cancer research.
Quantitative proteomics of intestinal mucosa from male mice lacking intestinal epithelial insulin receptors.
Endocrinology. 2017 Jun 07;:
HLA-DP(84Gly) constitutively presents endogenous peptides generated by the class I antigen processing pathway.
Nat Commun. 2017 May 10;8:15244
Curr Protoc Protein Sci. 2017 Feb 02;87:24.9.1-24.9.12
Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
Int J Cancer. 2016 Oct 17;:
Ectopic miR-125a Expression Induces Long-Term Repopulating Stem Cell Capacity in Mouse and Human Hematopoietic Progenitors.
Cell Stem Cell. 2016 Jul 12;
Development. 2016 Jul 1;143(13):e1.1
Nat Commun. 2016;7:11906
PTP1B controls non-mitochondrial oxygen consumption by regulating RNF213 to promote tumour survival during hypoxia.
Nat Cell Biol. 2016 Jun 20;
J Cell Sci. 2016 May 13;
Senior Scientist, Princess Margaret Cancer Centre